You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas: Autoimmune
28 March 2023 - - The global bioengineered protein drugs market was estimated to have been worth USD 327.6bn in 2021, according to a report from Dublin-based Research and Markets.
Between...
Between...
24 March 2023 - - US-based late-stage precision immunology biopharmaceutical company NImmune Biopharma has launched following the acquisition of omilancor, NIM-1324, and the entire LANCL portfoli...
22 March 2023 - - Bioelectronic medicine researchers at The Feinstein Institutes for Medical Research have developed a new method for studying neural signals transmitted to the brain through...
21 March 2023 - - Tennessee, US-based ImmunoTek Bio Centers has opened its newest ImmunoTek Plasma location in Morristown, the company said.
As the world's largest independent blood and pla...
As the world's largest independent blood and pla...
16 March 2023 - - The US Food and Drug Administration has cleared the Investigational New Drug Application for VX-264, a stem cell-derived, fully differentiated pancreatic islet cell therapy encapsula...
14 March 2023 - - US-based Abata Therapeutics, a company focused on translating the biology of regulatory T cells (Tregs) into transformational medicines for patients living with severe autoimmune and...
Related Headlines
Schrödinger Receives USD 111.3m Distribution from Sale of Nimbus's TYK2 Inhibitor to Takeda
Summit Therapeutics Closes Deal with Akeso to In-License Innovative Bispecific Antibody
Dr. Reddy's concludes clinical studies of rituximab biosimilar for filing in US, Europe